Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

Anne Rogiers; Jennifer De Cremer; Gil Awada; Julia Katharina Schwarze; Laila Ben Salama; Peter Theuns; Mark De Ridder; Bart Neyns

Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

Anne Rogiers, Jennifer De Cremer, Gil Awada, Julia Katharina Schwarze, Laila Ben Salama, Peter Theuns, Mark De Ridder, Bart Neyns

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2	English
Artikelnummer	07
Tijdschrift	Journal of Translational Medicine
Volume	17
Nummer van het tijdschrift	S1
Status	Published - 15 jan. 2019
Evenement	Immunotherapy Bridge 2018 and Melanoma Bridge 2018 - Napoli, Italy Duur: 28 nov. 2018 → 1 dec. 2018

Citeer dit

@article{c86c9bb0014645c7b4975a51cf9ce875,

title = "Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab",

keywords = "advanced melanoma survivors, pembrolizumab",

author = "Anne Rogiers and {De Cremer}, Jennifer and Gil Awada and Schwarze, {Julia Katharina} and {Ben Salama}, Laila and Peter Theuns and {De Ridder}, Mark and Bart Neyns",

year = "2019",

month = jan,

day = "15",

language = "English",

volume = "17",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central",

number = "S1",

note = "Immunotherapy Bridge 2018 and Melanoma Bridge 2018 ; Conference date: 28-11-2018 Through 01-12-2018",

}

TY - JOUR

T1 - Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

AU - Rogiers, Anne

AU - De Cremer, Jennifer

AU - Awada, Gil

AU - Schwarze, Julia Katharina

AU - Ben Salama, Laila

AU - Theuns, Peter

AU - De Ridder, Mark

AU - Neyns, Bart

PY - 2019/1/15

Y1 - 2019/1/15

KW - advanced melanoma survivors

KW - pembrolizumab

M3 - Meeting abstract (Journal)

SN - 1479-5876

VL - 17

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

IS - S1

M1 - 07

T2 - Immunotherapy Bridge 2018 and Melanoma Bridge 2018

Y2 - 28 November 2018 through 1 December 2018

ER -